Cognitive functioning in a hypnotic drug trial
โ Scribed by David Wheatley
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 423 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
โฆ Synopsis
In a 2 week comparative trial between lormetazepam (LMA) and temazepam (TEM) in 162 insomniac patients, Critical Flicker Fusion Threshhold (CFFT) and Digit Symbol Substitution (DSS) tests were performed, pre-treatment and at days 7 and 14. With neither drug was there any difference in C m , but highly significant improvement in DSS (p < 0.001). Patients completed daily visual analogue scales concerned with various sleep parameters and daytime effects. Sleep was significantly improved with both drugs from day 1 onwards, as were daytime general wellbeing and alertness. There was significant improvement in daytime balance and coordination in the LMA group (p < 0-001 by day 14) but not in the TEM group. Daytime anxiety improved significantly in both groups, but on day 14 this improvement was still significant in the LMA group (p < 0.001) but not in the TEM group. The incidence of daytime fatigue (p < 0.001), drowsiness (p < 0.02) and headache (p < 0.001) were significantly reduced with LMA and daytime fatigue (p < 0-01) and headache (p < 0.001) with TEM, but with no significant between group differences. The severity of daytime fatigue was significantly less with LMA than with TEM (p < 0-05).
๐ SIMILAR VOLUMES
Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (
## Abstract ## BACKGROUND: The current study was performed to determine whether neuropsychologic functioning differs in breast cancer survivors 6 months after the completion of adjuvant treatment compared with women without cancer. ## METHODS: Participants were 187 women who were diagnosed with
## Abstract ## Objective Benzodiazepines (BZDs) have been reported to cause negative impacts on body stability and cognitive functions, which in turn could result in lethal incidents, including falls, especially in the elderly. This fact notwithstanding, no systematic trial has evaluated the feasi
## Abstract A consensus conference on the topic of clinical drug trials in cognitive disorders of the elderly was held in Marseille on January 28โ29, 1993. At the end of this conference, several recommendations were made. Drugs used in trials must be chosen according to solid neurobiological eviden